Published in Transplantation on February 15, 1995
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut (2007) 4.51
Guidelines on the management of ascites in cirrhosis. Gut (2006) 1.81
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transpl (2011) 1.44
Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant (2011) 1.17
Acute renal dysfunction in liver diseases. World J Gastroenterol (2007) 1.15
Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci (2007) 1.13
Kidneys in chronic liver diseases. World J Gastroenterol (2012) 1.10
Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl (2009) 1.06
The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant (2005) 1.02
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology (1997) 1.00
Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol (2013) 0.99
Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg (2008) 0.96
Hepatorenal syndrome. World J Gastroenterol (2012) 0.93
Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci (2003) 0.84
The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study. BMC Nephrol (2013) 0.83
Metabolic and cardiovascular complications in the liver transplant recipient. Ann Gastroenterol (2015) 0.82
Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies. Dig Dis Sci (2011) 0.80
Hyponatremia and Hepatorenal Syndrome. Gastroenterol Hepatol (N Y) (2015) 0.79
Experience without using venoveno bypass in adult orthotopic liver transplantation. Korean J Anesthesiol (2011) 0.78
Systemic abnormalities in liver disease. World J Gastroenterol (2009) 0.78
Optimal management of hepatorenal syndrome in patients with cirrhosis. Hepat Med (2010) 0.78
Hepatorenal syndrome: outcome of response to therapy and predictors of survival. Gastroenterol Res Pract (2015) 0.78
Hepatorenal Syndrome. Curr Treat Options Gastroenterol (2000) 0.77
Liver transplantation(). J Ultrasound (2007) 0.77
Impact of preoperative chronic renal failure on liver transplantation: a population-based cohort study. Ther Clin Risk Manag (2016) 0.75
Evidence for the immunosuppressive potential of calcineurin inhibitor-sparing regimens in liver transplant recipients with impaired renal function. J Transplant (2011) 0.75
Recipient Age and Mortality Risk after Liver Transplantation: A Population-Based Cohort Study. PLoS One (2016) 0.75
Simultaneous Liver-Kidney Transplantation. Curr Transplant Rep (2015) 0.75
Renal failure in cirrhosis: Emerging concepts. World J Hepatol (2015) 0.75
Renal dysfunction in cirrhosis: diagnosis, treatment and prevention. MedGenMed (2004) 0.75
Acute Kidney Injury in Patients with Cirrhosis. J Clin Transl Hepatol (2015) 0.75
Outcomes of liver transplantation in patients with hepatorenal syndrome. World J Hepatol (2016) 0.75
Progress in treatment of massive ascites and hepatorenal syndrome. World J Gastroenterol (2006) 0.75
Hepatorenal syndrome: aetiology, diagnosis, and treatment. Gastroenterol Res Pract (2015) 0.75
The benefit of sirolimus maintenance immunosuppression and rabbit antithymocyte globulin induction in liver transplant recipients that develop acute kidney injury in the early postoperative period. J Transplant (2015) 0.75
End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease. Clin Transplant (2014) 0.75
A Case of Hepatorenal Syndrome and Abdominal Compartment Syndrome with High Renal Congestion. Am J Case Rep (2017) 0.75
Rescue management of early complications after liver transplantation-key for the long-term success. Langenbecks Arch Surg (2016) 0.75
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Genome sequence of the plant pathogen Ralstonia solanacearum. Nature (2002) 6.23
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
Familial Mediterranean fever. Lancet (1998) 4.16
Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet (1994) 4.12
Quasars revisited: rapid time variations observed via very-long-baseline interferometry. Science (1971) 3.97
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature (2000) 3.61
Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med (1974) 3.57
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
General practice audit of asthma in childhood. Br Med J (Clin Res Ed) (1984) 2.98
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Reasons for possible failure of inoculation to enhance biodegradation. Appl Environ Microbiol (1985) 2.82
Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect Immun (1996) 2.80
Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med (1994) 2.45
Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril (2001) 2.44
Immunosuppression, generic drugs and the FDA. Am J Transplant (2011) 2.43
Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol (2001) 2.30
Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? Ann Oncol (2005) 2.20
Amplification and purification of UvrA, UvrB, and UvrC proteins of Escherichia coli. J Biol Chem (1985) 2.11
Boy Scouts of America policy on homosexuality. Arch Pediatr Adolesc Med (2001) 2.03
Shipment of human islets for transplantation. Am J Transplant (2007) 2.01
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Paracetamol overdose in Jerusalem, 1984-89. Isr J Med Sci (1992) 1.91
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90
Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology (1993) 1.90
Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg (1982) 1.84
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation (2001) 1.79
Alport's syndrome. A report of 58 cases and a review of the literature. Am J Med (1981) 1.78
Strategy for the detection of Helicobacter species by amplification of 16S rRNA genes and identification of H. felis in a human gastric biopsy. Res Microbiol (1997) 1.65
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection (2009) 1.64
Lawsonia intracellularis proliferative enteropathy in a weanling foal. Equine Vet J (1998) 1.63
Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int (1975) 1.59
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression. Am J Transplant (2011) 1.56
H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int (1986) 1.55
Concentration by evaporation and the prebiotic synthesis of cytosine. Orig Life Evol Biosph (2001) 1.54
Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet (2001) 1.54
Risk factors for breast cancer. Am J Epidemiol (1983) 1.54
Readmission to the intensive care unit after liver transplantation. Crit Care Med (2001) 1.54
Characteristics of pregnant women who engage in binge alcohol consumption. CMAJ (1997) 1.53
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51
Metallic stents for the treatment of intrahepatic biliary strictures after liver transplantation. J Vasc Interv Radiol (1996) 1.51
Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology (1995) 1.51
Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most. Intern Med J (2007) 1.50
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50
Surgical removal of echocardiographically detected multiple pedunculated and mobile left ventricular thrombi in acute myocardial infarction. Isr J Med Sci (1989) 1.49
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42
De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg (1998) 1.42
The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41
Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery (1997) 1.41
Unscientific assertions on treating asthma in general practice. BMJ (1994) 1.41
Cryptococcosis after renal transplantation: report of ten cases. Surgery (1976) 1.41
Familial Mediterranean fever in the "Chuetas" of Mallorca--origin in inquisition? Isr J Med Sci (1995) 1.39
Radar Observations of Jupiter quency shift which observed. Science (1964) 1.39
Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation (1981) 1.38
Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther (1978) 1.38
The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation (1990) 1.37
Colchicine: 1998 update. Semin Arthritis Rheum (1998) 1.36
Evaluation of a yoga based regimen for treatment of osteoarthritis of the hands. J Rheumatol (1994) 1.35
The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol (1978) 1.35
Prison health services. BMJ (1997) 1.35
Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther (1995) 1.33
Bilateral spontaneous and simultaneous rupture of the quadriceps tendons in gout. J Bone Joint Surg Br (1971) 1.33
Alpha heavy chain disease. A variant of Mediterranean lymphoma. Arch Intern Med (1971) 1.32
Polymorphic acetylation procainamide in man. Clin Pharmacol Ther (1975) 1.32
The use of glucose oxidase as a generator of H 2 O 2 in the enzymatic radioiodination of components of cell surfaces. Cell Immunol (1972) 1.31
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant (2011) 1.29
Alport's syndrome: experience at Hôpital Necker. Kidney Int Suppl (1982) 1.25
Educating the student, informing the physician on nutrition. J Med Assoc Ga (1980) 1.24
Breast cancer and alcoholic-beverage consumption. Lancet (1982) 1.22
Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol (1974) 1.21
Sibling species of cercospora associated with gray leaf spot of maize. Phytopathology (1998) 1.20
The self-reported health status of prisoners in New South Wales. Aust N Z J Public Health (2004) 1.20
Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ (1998) 1.20
Hypothermic circulatory arrest and other methods of cerebral protection during operations on the thoracic aorta. J Card Surg (1994) 1.20
Is liver transplantation indicated for cholangiocarcinoma? Am J Surg (1993) 1.20
Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients. Transplantation (1991) 1.18
Microcapsule artificial kidney: treatment of patients with acute drug intoxication. Can Med Assoc J (1973) 1.17